ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,504Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 761

$410K Total Retail Price of All Prescriptions

Rank: 200 out of 761

471 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 9,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 626 599 1 2
LEVOTHYROXINE SODIUM 623 585 2 3
LISINOPRIL 556 519 3 1
OMEPRAZOLE 430 384 4 4
AMLODIPINE BESYLATE 290 266 5 6
HYDROCODONE-ACETAMINOPHEN 279 241 S3 6 5
ATORVASTATIN CALCIUM 238 218 7 12
ATENOLOL 232 221 8 8
CITALOPRAM HBR 215 202 9 19
FUROSEMIDE 206 202 10 7
ALENDRONATE SODIUM 205 205 11 21
WARFARIN SODIUM 195 191 12 9
GLIPIZIDE 187 182 13 39
METOPROLOL TARTRATE 182 180 14 14
METOPROLOL SUCCINATE 173 157 15 16
HYDROCHLOROTHIAZIDE 166 160 16 11
GABAPENTIN 162 118 17 15
METFORMIN HCL 150 141 18 10
LOVASTATIN 147 143 19 17
POTASSIUM CHLORIDE 142 138 20 18
ZOLPIDEM TARTRATE 140 129 21 22
DONEPEZIL HCL 130 130 22 33
LOSARTAN POTASSIUM 126 123 23 13
PRAVASTATIN SODIUM 122 121 24 20
RANITIDINE HCL 106 102 25 52
MORPHINE SULFATE ER 102 55 S2 26 38
ALLOPURINOL 99 99 27 28
TAMSULOSIN HCL 94 90 28 27
FLUTICASONE PROPIONATE 92 81 29 29
FLUOXETINE HCL 87 84 30 31
TRAZODONE HCL 81 66 31 23
OXYCODONE-ACETAMINOPHEN 80 61 S2 32 49
OXYCODONE HCL 79 45 S2 33 24
CALCITRIOL 74 74 34 146
DILTIAZEM 24HR CD 74 71 34 132
CARVEDILOL 71 71 36 26
GLYBURIDE 61 61 R 37 77
ADVAIR DISKUS 60 54 38 37
CIPROFLOXACIN HCL 60 58 38 63
OXYBUTYNIN CHLORIDE 58 58 40 85
ENALAPRIL MALEATE 55 52 41 71
CYCLOBENZAPRINE HCL 54 36 R 42 51
DIGOXIN 54 54 42 43
HYDROMORPHONE HCL 53 0 S2 44 140
PROAIR HFA 51 45 45 32
METHADONE HCL 50 15 S2 46 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.